Literature DB >> 24577878

Effect of cardiac rehabilitation on functional and emotional status in patients after transcatheter aortic-valve implantation.

Heinz Völler1, Annett Salzwedel2, Aischa Nitardy3, Hermann Buhlert3, András Treszl4, Karl Wegscheider4.   

Abstract

BACKGROUND: Transcatheter aortic-valve implantation (TAVI) is an established alternative therapy in patients with severe aortic stenosis and a high surgical risk. Despite a rapid growth in its use, very few data exist about the efficacy of cardiac rehabilitation (CR) in these patients. We assessed the hypothesis that patients after TAVI benefit from CR, compared to patients after surgical aortic-valve replacement (sAVR).
METHODS: From September 2009 to August 2011, 442 consecutive patients after TAVI (n = 76) or sAVR (n = 366) were referred to a 3-week CR. Data regarding patient characteristics as well as changes of functional (6-min walk test. 6-MWT), bicycle exercise test), and emotional status (Hospital Anxiety and Depression Scale) were retrospectively evaluated and compared between groups after propensity score adjustment.
RESULTS: Patients after TAVI were significantly older (p < 0.001), more female (p < 0.001), and had more often coronary artery disease (p = 0.027), renal failure (p = 0.012) and a pacemaker (p = 0.032). During CR, distance in 6-MWT (both groups p ≤ 0.001) and exercise capacity (sAVR p ≤ 0.001, TAVI p ≤ 0.05) significantly increased in both groups. Only patients after sAVR demonstrated a significant reduction in anxiety and depression (p ≤ 0.001). After propensity scores adjustment, changes were not significantly different between sAVR and TAVI, with the exception of 6-MWT (p = 0.004).
CONCLUSIONS: Patients after TAVI benefit from cardiac rehabilitation despite their older age and comorbidities. CR is a helpful tool to maintain independency for daily life activities and participation in socio-cultural life. © The European Society of Cardiology 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Cardiac rehabilitation; emotional status; functional capacity; surgical aortic valve replacement (sAVR); transcatheter aortic valve implantation (TAVI)

Mesh:

Year:  2014        PMID: 24577878     DOI: 10.1177/2047487314526072

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  18 in total

Review 1.  [Exercise training in the therapy of heart diseases: Current evidence and future options].

Authors:  S Schwarz; A Boscheri; J Christle; A Duvinage; K Esefeld; H Fricke; N Pitsch; A Pressler; M Weichenberger; M Halle
Journal:  Herz       Date:  2016-03       Impact factor: 1.443

2.  The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019.

Authors:  Nabil Ghorayeb; Ricardo Stein; Daniel Jogaib Daher; Anderson Donelli da Silveira; Luiz Eduardo Fonteles Ritt; Daniel Fernando Pellegrino Dos Santos; Ana Paula Rennó Sierra; Artur Haddad Herdy; Claúdio Gil Soares de Araújo; Cléa Simone Sabino de Souza Colombo; Daniel Arkader Kopiler; Filipe Ferrari Ribeiro de Lacerda; José Kawazoe Lazzoli; Luciana Diniz Nagem Janot de Matos; Marcelo Bichels Leitão; Ricardo Contesini Francisco; Rodrigo Otávio Bougleux Alô; Sérgio Timerman; Tales de Carvalho; Thiago Ghorayeb Garcia
Journal:  Arq Bras Cardiol       Date:  2019-03       Impact factor: 2.000

Review 3.  The role of cardiac rehabilitation in patients with heart disease.

Authors:  Sean R McMahon; Philip A Ades; Paul D Thompson
Journal:  Trends Cardiovasc Med       Date:  2017-02-15       Impact factor: 6.677

Review 4.  [Postacute care after transcatheter aortic valve implantation (TAVI)].

Authors:  Robert Michael Nechwatal; Kurt Bestehorn; Florian Leuschner; Andreas Hagendorff; Manju Guha; Axel Schlitt
Journal:  Herz       Date:  2020-04-20       Impact factor: 1.443

Review 5.  The potential role of endogenous bacteriophages in controlling invading pathogens.

Authors:  Andrzej Górski; Beata Weber-Dabrowska
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

6.  Survey Reported Participation in Cardiac Rehabilitation and Survival After Mitral or Aortic Valve Surgery.

Authors:  Quinn R Pack; Brian D Lahr; Ray W Squires; Francisco Lopez-Jimenez; Kevin L Greason; Hector I Michelena; Kashish Goel; Randal J Thomas
Journal:  Am J Cardiol       Date:  2016-04-05       Impact factor: 2.778

Review 7.  Transcatheter aortic valve implantation in the elderly: who to refer?

Authors:  Matthew Finn; Philip Green
Journal:  Prog Cardiovasc Dis       Date:  2014-08-12       Impact factor: 8.194

8.  Association of Depression With Mortality in Older Adults Undergoing Transcatheter or Surgical Aortic Valve Replacement.

Authors:  Laura M Drudi; Matthew Ades; Sena Turkdogan; Caroline Huynh; Sandra Lauck; John G Webb; Nicolo Piazza; Giuseppe Martucci; Yves Langlois; Louis P Perrault; Anita W Asgar; Marino Labinaz; Andre Lamy; Nicolas Noiseux; Mark D Peterson; Rakesh C Arora; Brian R Lindman; Melissa Bendayan; Rita Mancini; Amanda Trnkus; Dae H Kim; Jeffrey J Popma; Jonathan Afilalo
Journal:  JAMA Cardiol       Date:  2018-03-01       Impact factor: 14.676

Review 9.  Interventions for Frailty Among Older Adults With Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Naila Ijaz; Brian Buta; Qian-Li Xue; Denise T Mohess; Archana Bushan; Henry Tran; Wayne Batchelor; Christopher R deFilippi; Jeremy D Walston; Karen Bandeen-Roche; Daniel E Forman; Jon R Resar; Christopher M O'Connor; Gary Gerstenblith; Abdulla A Damluji
Journal:  J Am Coll Cardiol       Date:  2022-02-08       Impact factor: 24.094

10.  Frailty in patients undergoing transcatheter aortic valve replacement: from risk scores to frailty-based management.

Authors:  Andreas Tzoumas; Damianos G Kokkinidis; Stefanos Giannopoulos; George Giannakoulas; Leonidas Palaiodimos; Dimitrios V Avgerinos; Polydoros N Kampaktsis; Robert T Faillace
Journal:  J Geriatr Cardiol       Date:  2021-06-28       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.